238 related articles for article (PubMed ID: 1376397)
1. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
2. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
3. Interferons. New additions and indications for use.
Stadler R; Ruszczak Z
Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
5. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
6. Biologic response modifiers: the interferon alfa experience.
Koeller JM
Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
[TBL] [Abstract][Full Text] [Related]
7. Interferons in the management of viral hepatitis.
Zein NN
Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
[TBL] [Abstract][Full Text] [Related]
8. Criteria for use of interferon alfa-2a or interferon alfa-2b for selected indications in adults.
Am J Hosp Pharm; 1994 Apr; 51(8):1030-3. PubMed ID: 7518650
[No Abstract] [Full Text] [Related]
9. Current status of interferons in the treatment of cancer.
Hansen RM; Borden EC
Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
[TBL] [Abstract][Full Text] [Related]
10. The interferons and their use in condyloma acuminata.
Browder JF; Araujo OE; Myer NA; Flowers FP
Ann Pharmacother; 1992 Jan; 26(1):42-5. PubMed ID: 1376628
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effects of recombinant interferon alfa and clinical experience in viral infections.
Schneider HT; Goldmann U
Arzneimittelforschung; 1989 Dec; 39(12):1608-12. PubMed ID: 2696467
[TBL] [Abstract][Full Text] [Related]
12. Interferon and other biologic agents for the treatment of Kaposi's sarcoma.
Krown SE
Hematol Oncol Clin North Am; 1991 Apr; 5(2):311-22. PubMed ID: 1708760
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C: limits and dose regimen of interferon alfa.
Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
[TBL] [Abstract][Full Text] [Related]
15. The interferons.
Itri LM
Cancer; 1992 Aug; 70(4 Suppl):940-5. PubMed ID: 1379116
[TBL] [Abstract][Full Text] [Related]
16. Therapy of hepatitis C: overview.
Lindsay KL
Hepatology; 1997 Sep; 26(3 Suppl 1):71S-77S. PubMed ID: 9305668
[TBL] [Abstract][Full Text] [Related]
17. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal.
Dusheiko GM; Roberts JA
Hepatology; 1995 Dec; 22(6):1863-73. PubMed ID: 7489999
[TBL] [Abstract][Full Text] [Related]
20. Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Salk A; Stobaugh DJ; Deepak P; Ehrenpreis ED
Ann Pharmacother; 2013 Apr; 47(4):537-42. PubMed ID: 23535814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]